硬斑病性秃发研究进展

doi:10.35541/cjd.20220829

中华皮肤科杂志 ›› 2024, e20220829.doi: 10.35541/cjd.20220829

硬斑病性秃发研究进展

陶秋薇陈启韬邵光辉李煜乾朱麒麟朱晶李中明杜旭峰

南京医科大学附属无锡人民医院皮肤科无锡医学中心，无锡 214000

收稿日期:2022-11-22 修回日期:2023-10-08 发布日期:2024-05-08
通讯作者: 杜旭峰 E-mail:xufengdu@njmu.edu.cn
基金资助:
南京医科大学无锡医学中心专病队列和临床研究项目（WMCC202306）；南京医科大学科技发展基金一般项目（NMUB20220175）；无锡市卫生健康委科研项目（Z202319）

Morphea alopecia

Tao Qiuwei, Chen Qitao, Shao Guanghui, Li Yuqian, Zhu Qilin, Zhu Jing, Li Zhongming, Du Xufeng

Department of Dermatology, the Affiliated Wuxi People′s Hospital of Nanjing Medical University, Wuxi Medical Center, Wuxi 214000, Jiangsu, China

Received:2022-11-22 Revised:2023-10-08 Published:2024-05-08
Contact: Du Xufeng E-mail:xufengdu@njmu.edu.cn
Supported by:
Cohort and Clinical Research Program of Wuxi Medical Center, Nanjing Medical University （WMCC202306）; Science and Technology Development Fund of Nanjing Medical University-General Project （NMUB20220175）; Wuxi Health Commission Scientific Research Project （Z202319）

摘要/Abstract

摘要： 【摘要】硬斑病性秃发是一种少见的继发性瘢痕性秃发，常由头皮线状硬皮病引起。当脱发作为硬斑病的唯一症状时，该病易与其他局限性脱发疾病混淆，需要通过组织病理、皮肤镜等检查手段鉴别。本文综述硬斑病性秃发的发病机制、临床病理表现、诊断与治疗等方面的研究进展，以提高临床医师对本病的认识。

关键词: 秃发, 硬皮病, 局部性, 硬斑病性秃发, 瘢痕性秃发, 硬斑病, 线状硬皮病

Abstract: 【Abstract】 Morphea alopecia is a rare secondary cicatricial alopecia, often caused by linear scleroderma of the scalp. When the hair loss becomes the only symptom of morphea, it is easily confused with other localized alopecia. The diagnosis of morphea alopecia depends on histopathologic and dermoscopic examinations. In order to improve the understanding of morphea alopecia among clinicians, this review summarizes research progress in its pathogenesis, clinical and pathological characteristics, diagnosis and treatment.

Key words: Alopecia, Scleroderma, localized, Morphea alopecia, Cicatricial alopecia, Morphea, Linear scleroderma

陶秋薇陈启韬邵光辉李煜乾朱麒麟朱晶李中明杜旭峰. 硬斑病性秃发研究进展[J]. 中华皮肤科杂志, 2024,e20220829. doi:10.35541/cjd.20220829

Tao Qiuwei, Chen Qitao, Shao Guanghui, Li Yuqian, Zhu Qilin, Zhu Jing, Li Zhongming, Du Xufeng. Morphea alopecia[J]. Chinese Journal of Dermatology,2024,e20220829. doi:10.35541/cjd.20220829

参考文献 51

［1］	Snarskaya ES, Vasileva KD. Localized scleroderma: actual insights and new biomarkers［J］. Int J Dermatol, 2022,61（6）:667⁃674. doi: 10.1111/ijd.15811.
［2］	Glaser DH, Schutt C, VonVille HM, et al. Linear scleroderma of the head ⁃ updates in management of Parry Romberg syndrome and en coup de sabre: a rapid scoping review across subspecialties［J］. Eur J Rheumatol, 2020,7（Suppl1）:S48⁃S57. doi: 10.5152/eurjrheum.2019.19183.
［3］	Chiu YE, Shmuylovich L, Kiguradze T, et al. Body site distribution of pediatric⁃onset morphea and association with extracutaneous manifestations［J］. J Am Acad Dermatol, 2021,85（1）:38⁃45. doi: 10.1016/j.jaad.2021.03.017.
［4］	Zaaroura H, Pope E, Laxer RM, et al. Reversible alopecia in en coup de sabre morphea［J］. Pediatr Dermatol, 2021,38（6）:1532⁃1534. doi: 10.1111/pde.14827.
［5］	Pierre⁃Louis M, Sperling LC, Wilke MS, et al. Distinctive histopathologic findings in linear morphea （en coup de sabre） alopecia［J］. J Cutan Pathol, 2013,40（6）:580⁃584. doi: 10.1111/cup.12124.
［6］	Finner AM, Otberg N, Shapiro J. Secondary cicatricial and other permanent alopecias［J］. Dermatol Ther, 2008,21（4）:279⁃294. doi: 10.1111/j.1529⁃8019.2008.00210.x.
［7］	Goh C, Biswas A, Goldberg LJ. Alopecia with perineural lymphocytes: a clue to linear scleroderma en coup de sabre［J］. J Cutan Pathol, 2012,39（5）:518⁃520. doi: 10.1111/j.1600⁃0560. 2012.01889.x.
［8］	de Marsillac PF, Cortez de Almeida RF, Machado CJ, et al. Clinical, epidemiological, trichoscopic and histopathological features of linear morphea on the scalp［J］. J Eur Acad Dermatol Venereol, 2022,36（11）:e892⁃e895. doi: 10.1111/jdv.18323.
［9］	Asano Y, Ihn H, Tamaki K. An unusual manifestation of linear scleroderma ′en coup de sabre′ on the vertex and frontoparietal regions［J］. Clin Exp Dermatol, 2007,32（6）:758⁃759. doi: 10. 1111/j.1365⁃2230.2007.02521.x.
［10］	Saceda⁃Corralo D, Tosti A. Trichoscopic features of linear morphea on the scalp［J］. Skin Appendage Disord, 2018,4（1）:31⁃33. doi: 10.1159/000478022.
［11］	Vázquez Sánchez M, Fuentelsaz Del Barrio MV, Conejero Del Mazo R, et al. Linear morphea in saber coup: about a case［J］. Arch Argent Pediatr, 2022,120（2）:e75⁃e79. doi: 10.5546/aap. 2022.e75.
［12］	王友力, 罗宏宾, 曹毅, 等. 枕部线状硬皮病1例［J］. 现代中西医结合杂志, 2009,18（27）:3364⁃3365. doi: 10.3969/j.issn.1008⁃8849.2009.27.074.
［13］	Wenzel D, Haddadi NS, Afshari K, et al. Upcoming treatments for morphea［J］. Immun Inflamm Dis, 2021,9（4）:1101⁃1145. doi: 10.1002/iid3.475.
［14］	Hixon AM, Christensen E, Hamilton R, et al. Epilepsy in Parry⁃Romberg syndrome and linear scleroderma en coup de sabre: case series and systematic review including 140 patients［J］. Epilepsy Behav, 2021,121（Pt A）:108068. doi: 10.1016/j.yebeh. 2021.108068.
［15］	Polcari I, Moon A, Mathes EF, et al. Headaches as a presenting symptom of linear morphea en coup de sabre［J］. Pediatrics, 2014,134（6）:e1715⁃e1719. doi: 10.1542/peds.2014⁃0019.
［16］	Oh YH, Lee SH. Frontal linear scleroderma （en coup de sabre）: a case report［J］. Cleft Palate Craniofac J, 2022,59（4）:538⁃542. doi: 10.1177/10556656211013168.
［17］	Creadore A, Watchmaker J, Maymone M, et al. Cosmetic treatment in patients with autoimmune connective tissue diseases: best practices for patients with morphea/systemic sclerosis［J］. J Am Acad Dermatol, 2020,83（2）:315⁃341. doi: 10.1016/j.jaad. 2019.12.081.
［18］	刘金娟, 刘彤. Wnt2、Wnt3a和β⁃catenin在硬皮病患者皮损中的作用［J］. 南方医科大学学报, 2012,32（12）:1781⁃1786. doi: 10.3969/j.issn.1673⁃4254.2012.12.021.
［19］	Imhof RL, Cantwell HM, Proffer SL, et al. The spectrum of pediatric scarring alopecia: a retrospective review of 27 patients seen at Mayo clinic［J］. Pediatr Dermatol, 2021,38（3）:580⁃584. doi: 10.1111/pde.14543.
［20］	Hordinsky M. Scarring alopecia: diagnosis and new treatment options［J］. Dermatol Clin, 2021,39（3）:383⁃388. doi: 10.1016/j.det.2021.05.001.
［21］	Villablanca S, Fischer C, García⁃García SC, et al. Primary scarring alopecia: clinical⁃pathological review of 72 cases and review of the literature［J］. Skin Appendage Disord, 2017,3（3）:132⁃143. doi: 10.1159/000467395.
［22］	Toyama S, Sato S, Asano Y. Localized scleroderma histologically characterized by liquefaction degeneration and upper dermis fibrosis: a possible association with chemotherapy［J］. Clin Exp Dermatol, 2020,45（5）:632⁃634. doi: 10.1111/ced.14216.
［23］	Walker D, Susa JS, Currimbhoy S, et al. Histopathological changes in morphea and their clinical correlates: results from the Morphea in Adults and Children Cohort V［J］. J Am Acad Dermatol, 2017,76（6）:1124⁃1130. doi: 10.1016/j.jaad.2016.12. 020.
［24］	Sonthalia S, Agrawal M, Sharma P, et al. Linear patch of alopecia in a child: trichoscopy reveals the actual diagnosis［J］. Skin Appendage Disord, 2019,5（6）:409⁃412. doi: 10.1159/000500096.
［25］	Saceda⁃Corralo D, Nusbaum AG, Romanelli P, et al. A case of circumscribed scalp morphea with perineural lymphocytes on pathology［J］. Skin Appendage Disord, 2017,3（4）:175⁃178. doi: 10.1159/000471855.
［26］	Zhang S, Zhu QL, Xiao MS, et al. The value of dermoscopy and high⁃frequency ultrasound in staging morphea［J］. J Dermatol, 2023,50（4）:511⁃517. doi: 10.1111/1346⁃8138.16648.
［27］	Meng L, Wang Q. Neuroimaging findings of linear scleroderma of the head and face: a case report［J］. J Int Med Res, 2022,50（1）:3000605 211066002. doi: 10.1177/03000605211066002.
［28］	Alwash N, Dinani N, Felton J. A case of multiple cerebral cavernomas associated with en coup de sabre scleroderma［J］. Pediatr Dermatol, 2020,37（1）:237⁃238. doi: 10.1111/pde.14052.
［29］	Martins R, Quintas S, Coelho J, et al. Extensive linear scleroderma en coup de sabre with exertion⁃induced hemiplegic migraine［J］. Mult Scler Relat Disord, 2020,37:101457. doi: 10.1016/j.msard.2019.101457.
［30］	Seese RR, Glaser D, Furtado A, et al. Unilateral neuroimaging findings in pediatric craniofacial scleroderma: Parry⁃Romberg syndrome and en coup de sabre［J］. J Child Neurol, 2020,35（11）:753⁃762. doi: 10.1177/0883073820931253.
［31］	Jindal AK, Handa S, Loganathan SK, et al. Juvenile localized scleroderma: a single⁃centre experience from India［J］. J Eur Acad Dermatol Venereol, 2023,37（3）:598⁃604. doi: 10.1111/jdv.18765.
［32］	Kim J, Chung KB, Lee YI, et al. Clinical characteristics and histopathologic changes of morphea: a single⁃center, retrospective study of 137 patients［J］. J Am Acad Dermatol, 2021,85（1）:105⁃113. doi: 10.1016/j.jaad.2020.11.006.
［33］	Romagnuolo M, Moltrasio C, Barbareschi M, et al. Circumscribed morphea of the scalp: an entity to be considered in the differential diagnosis of cicatricial alopecia［J］. Skin Appendage Disord, 2022,8（6）:500⁃503. doi: 10.1159/000525355.
［34］	Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options［J］. Clin Exp Med, 2021,21（2）:215⁃230. doi: 10.1007/s10238⁃020⁃00673⁃w.
［35］	Concha J, Werth VP. Alopecias in lupus erythematosus［J］. Lupus Sci Med, 2018,5（1）:e000291. doi: 10.1136/lupus⁃2018⁃000291.
［36］	Cantwell HM, Wieland CN, Proffer SL, et al. Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients［J］. Int J Dermatol, 2021,60（4）:482⁃488. doi: 10.1111/ijd.15285.
［37］	Peña⁃Romero AG, García⁃Romero MT. Diagnosis and manage⁃ment of linear scleroderma in children［J］. Curr Opin Pediatr, 2019,31（4）:482⁃490. doi: 10.1097/MOP.0000000000000785.
［38］	Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre （linear morphea subtype）［J］. J Dermatolog Treat, 2018,29（2）:197⁃199. doi: 10.1080/09546634. 2017.1341615.
［39］	Fadanelli G, Agazzi A, Vittadello F, et al. Methotrexate in linear scleroderma: long⁃term efficacy in fifty children from a single pediatric rheumatology center［J］. Arthritis Care Res （Hoboken）, 2021,73（9）:1259⁃1263. doi: 10.1002/acr.24260.
［40］	Weibel L, Theiler M, Howell KJ, et al. Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma （morphoea） to steroids and methotrexate using multi⁃modal imaging［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:1609⁃1616. doi: 10.1111/jdv.16308.
［41］	Khan MA, Shaw L, Eleftheriou D, et al. Radiologic improvement after early medical intervention in localised facial morphea［J］. Pediatr Dermatol, 2016,33（2）:e95⁃e98. doi: 10.1111/pde.12799.
［42］	Martini G, Saggioro L, Culpo R, et al. Mycophenolate mofetil for methotrexate⁃resistant juvenile localized scleroderma［J］. Rheumatology （Oxford）, 2021,60（3）:1387⁃1391. doi: 10.1093/rheumatology/keaa392.
［43］	McGaugh S, Kallis P, De Benedetto A, et al. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: a literature review［J］. Dermatol Ther, 2022,35（6）:e15437. doi: 10.1111/dth.15437.
［44］	Furuhashi T, Torii K, Ikumi K, et al. Ultraviolet A1 phototherapy for the treatment of localized scleroderma［J］. J Dermatol, 2020,47（7）:792⁃795. doi: 10.1111/1346⁃8138.15368.
［45］	Kato H, Shintani Y, Yamaguchi Y, et al. A surgical approach for stable lesions of linear scleroderma［J］. Kaohsiung J Med Sci, 2010,26（11）:621⁃623. doi: 10.1016/S1607⁃551X（10）70095⁃4.
［46］	Skorochod R, Nesher G, Gronovich Y. Management options for linear scleroderma （"en coup de sabre"）［J］. Dermatol Surg, 2022,48（10）:1038⁃1045. doi: 10.1097/DSS.0000000000003539.
［47］	Ayoub R, Saba SC. Treatment of linear scleroderma "en coup de sabre" with single⁃stage autologous fat grafting: a case report and review of the literature［J］. J Cosmet Dermatol, 2021,20（1）:285⁃289. doi: 10.1111/jocd.13490.
［48］	L′Orphelin JM, Garmi R, Labbé D, et al. Autologous fat grafting for the treatment of sclerotic lesions and scars［J］. Ann Dermatol Venereol, 2021,148（1）:40⁃44. doi: 10.1016/j.annder.2020.06.022.
［49］	Wang HC, Sun ET, Zhao RC, et al. Adipose⁃derived stem cells attenuate skin fibrosis and improve fat retention of a localized scleroderma mouse model［J］. Plast Reconstr Surg, 2023,151（1）:97⁃107. doi: 10.1097/PRS.0000000000009796.
［50］	Langridge BJ, Jeon FHK, Almadori A, et al. Autologous lipotransfer can improve the outcomes of localised scleroderma［J］. Clin Exp Rheumatol, 2021,Suppl 131（4）:159. doi: 10.55563/ clinexprheumatol/uczb6s.
［51］	戴叶芹, 许爱娥. 微小毛胚移植辅助治疗头皮线状硬皮病一例［J］. 中华皮肤科杂志, 2014,47（11）:826⁃827. doi: 10.3760/cma.j.issn.0412⁃4030.2014.011.019.

[1]	张硕张韡徐丹. 休止期脱发与新型冠状病毒感染的相关性及诊疗研究进展[J]. 中华皮肤科杂志, 2024, 57(8): 761-764.
[2]	徐经纬陈爽郭克磊韩立卞华. 微小RNA调控系统性硬皮病纤维化相关信号通路的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20230730-e20230730.
[3]	陈钰虹吕中法. 毛囊生长周期调控的机制进展[J]. 中华皮肤科杂志, 2024, 0(3): 20230226-e20230226.
[4]	杨洁刘莉萍. 单细胞测序在毛发相关研究中的应用[J]. 中华皮肤科杂志, 2024, 0(3): 20230292-e20230292.
[5]	汪丽俐杨斌罗颖. 女性雄激素性秃发患者614例家族史和血清双氢睾酮水平与其发病的相关性分析[J]. 中华皮肤科杂志, 2024, 57(12): 1127-1129.
[6]	王雨婷姚曼雪周乃慧. 联合微针治疗雄激素性秃发的研究进展[J]. 中华皮肤科杂志, 2024, 57(1): 82-84.
[7]	孙小洁刘毅. 抗雄激素药物治疗皮肤病研究进展[J]. 中华皮肤科杂志, 2023, 56(9): 882-885.
[8]	王俊霞郭伟楠陈慧郝军峰李冰卫静宜赵涛. 自体脂肪移植治疗40例稳定期线状硬斑病疗效回顾分析[J]. 中华皮肤科杂志, 2023, 56(8): 762-765.
[9]	沈雨晴宋秀祖. 紫外线与雄激素性脱发[J]. 中华皮肤科杂志, 2023, 0(2): 20210949-e20210949.
[10]	沙雨鸥魏珂璐林尽染刘庆梅倪春雅吴文育. 模式性分布的纤维化性秃发研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20220014-e20220014.
[11]	张莉宋秀祖. 血管内皮生长因子在雄激素性脱发中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20220240-e20220240.
[12]	邵光辉李煜乾陈启韬朱麒麟朱晶李中明杜旭峰范卫新. 先天性三角形秃发研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20220301-e20220301.
[13]	柴可喻江帆林彩虹唐冰思尤睿璇曾茁桐史雅倩邱湘宁湛意张桂英刘明辉肖嵘. 基于高频超声的局限性硬皮病皮损分期预测模型的建立及验证[J]. 中华皮肤科杂志, 2023, 56(11): 1008-1015.
[14]	李煜乾朱麒麟朱晶陈启韬李中明许文嵘杜旭峰范卫新. 前额纤维性秃发研究进展[J]. 中华皮肤科杂志, 2023, 56(10): 973-977.
[15]	冯华高英姝李清孙联文. 细胞力学在皮肤科的研究进展[J]. 中华皮肤科杂志, 2022, 55(7): 641-644.

硬斑病性秃发研究进展

Morphea alopecia

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 51

相关文章 15

Metrics

本文评价

推荐阅读 10